CFA
Financiado
The Clinical Flexible Analyzer a new generation IVD testing device aimed to inc...
The Clinical Flexible Analyzer a new generation IVD testing device aimed to increase the competitiveness of local healthcare vs. large laboratories
Increasing population and rise in chronic diseases have led to an enormous demand for faster and better in-vitro diagnostic tests of parameters for improved detection and cure of diseases. However, there is significant fragmentati...
Increasing population and rise in chronic diseases have led to an enormous demand for faster and better in-vitro diagnostic tests of parameters for improved detection and cure of diseases. However, there is significant fragmentation and separation in the IVD immunochemical analyzers market, depending on the end users’ size: on one hand there are large workstations (analyzers) capable of analyzing several parameters in one device, which are extremely large and pricey, and on the other hand, there are stand-alone devices with much narrower parameter testing, low throughput and efficiency, which are mainly based on 30 years old technology. These latter are the only option for smaller local clinics, which cannot afford the large, combined workstations, and thus, lose competitiveness to large laboratories who can afford them.
Our company, MEON Medical Solutions, is an Austrian based SME specialized in developing IVD medical devices for measurement of vital parameters to support medical professionals in clinical diagnostics. Our over 30 years of experience in the field enabled us to identify the business opportunity derived from the needs of small clinics and laboratories, for which we have developed the CFA – Clinical Flexible Analyzer- i.e. an innovative, automated, all-in-one immunochemical analyzer that combines the three most demanded diagnostic methods - Clinical Chemistry, Heterogeneous Immunoassays and Ion Selective Electrodes - in a single small modular, highly flexible and cost-efficient device. The CFA will enable small laboratories to provide an extremely cost-efficient local healthcare, and boost the growth of our company: We have estimated that after 5 years of CFA’s commercial launch in 2022, we will have engaged into 1,000 small clinics and hospitals globally, boosting the economic growth of our company, and enabling us to achieve a leading position over all other competitors.
ver más
Duración del proyecto: 3 meses
Fecha Inicio: 2018-11-19
Fecha Fin: 2019-02-28
Fecha Fin: 2019-02-28
Línea de financiación: concedida
El organismo H2020 notifico la concesión del proyecto el día 2019-02-28
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
EIC-SMEInst-2018-2020:
SME instrument
Cerrada
hace 6 años
Presupuesto
El presupuesto total del proyecto asciende a
71K€
Líder del proyecto
MEON MEDICAL SOLUTIONS GMBH CO KG
No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico
TRL
4-5
Perfil tecnológico
TRL
4-5
289.28K€ |
Participante